Biotechgate Global Database ›
Events & conferences in the Life Sciences industry
Below you find a list of upcoming events in the Life Sciences industry. We will be attending all events which are flagged with the Biotechgate / Venture Valuation logo.
If you are participating the conference and want to learn more, please contact us to schedule a meeting ››
Product & Company Valuation Course
04 Jun 23 - 04 Jun 23
Boston USA
The Product & Company Valuation course is designed to teach a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world. This introductory course is very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors which shape the risk profile of the company in question. This course optimally balances interactive lectures with practical group work exercises that are designed to help you practice the fundamental valuation tools & techniques taught throughout the day. Valuation is an inherently subjective task, which is made even more difficult in the life science industry due to its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies, IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the “Product Valuation and Deal Structuring” module where registrants will learn the commonly used rNPV (i.e., risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. Registrants will use an Excel-based tool designed specifically for this module, which can be taken home for future use.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in Product & Company Valuation Course
BIO International Convention 2023
05 Jun 23 - 08 Jun 23
Boston, USA
The BIO International Convention attracts 15,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy.
The BIO International Convention attracts 15,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in BIO International Convention 2023
RESI Boston
05 Jun 23 - 07 Jun 23
Boston, USA
The Redefining Early-Stage Investments (RESI) conference series brings together start-ups with early-stage investors and strategic channel partners to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. RESI is cross-border and cross-domain, connecting start-ups with ten categories of global investors across the silos of drugs, devices, diagnostics, and digital health. RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek seed, series A, and B funding.
The Redefining Early-Stage Investments (RESI) conference series brings together start-ups with early-stage investors and strategic channel partners to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. RESI is cross-border and cross-domain, connecting start-ups with ten categories of global investors across the silos of drugs, devices, diagnostics, and digital health. RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek seed, series A, and B funding.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in RESI Boston
Biotech CEO Summit Europe
12 Jun 23 - 14 Jun 23
Barcelona Spain
The Biotech CEO Summits are unlike most meetings CEOs attend. It is not an investor conference nor is it a business development conference. Rather, the Summits’ focus is on the CEOs and the challenges they have leading their companies. The program is modeled after a think tank-style meeting with discussions led by subject matter experts with input from the CEOs. The CEOs benefit from the wisdom and experiences shared by other participating CEOs and the discussants. The Summits operate under Chatham House Rules to encourage open and frank conversations. The number of participants is limited to allow full engagement. Registration is not open; one has to be asked to join this event. The Summits are closed to media and the sessions are not recorded in order to provide an extra layer of privacy.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in Biotech CEO Summit Europe
Brain Capital Innovation Summit
26 Jun 23 - 28 Jun 23
Santa Clara, California
USA
A convening of executive leaders in brain health innovation from research, the clinic, starts, industry, government & health systems. This summit is a boutique, by-invitation convening of key stakeholders at the confluence of brain research and technology - innovators, researchers, clinicians, educators, CEOs, investors, healthcare providers, and industry, coming together in an interactive round-table format to explore both the promise as well as the challenges to advancing innovation in brain capital innovation. Not only aimed at breakthrough research and high-potential companies, but as a call to action to define and implement the strategies and innovations required to drive systems level innovation in brain health; in our schools, sport, businesses, workplaces, health systems, and communities. This is why major State level, private sector, healthcare and investment actors like the California Mental Health Commission, the Meadows Mental Health Policy Institute from Texas, Intermountain Health from Utah, One Mind, PsyMed Ventures, GreyMatter Health, leading foundations, and some the largest family office wealth managers in the country, are coming together not only for the summit itself, but to help concrete, measurable systems level initiatives over the next two to three years. If you are active in brain health innovation in digital health, AI, deeptech, virtual reality, digital delivery of care, or health policy innovation, don’t miss it!
USA
A convening of executive leaders in brain health innovation from research, the clinic, starts, industry, government & health systems. This summit is a boutique, by-invitation convening of key stakeholders at the confluence of brain research and technology - innovators, researchers, clinicians, educators, CEOs, investors, healthcare providers, and industry, coming together in an interactive round-table format to explore both the promise as well as the challenges to advancing innovation in brain capital innovation. Not only aimed at breakthrough research and high-potential companies, but as a call to action to define and implement the strategies and innovations required to drive systems level innovation in brain health; in our schools, sport, businesses, workplaces, health systems, and communities. This is why major State level, private sector, healthcare and investment actors like the California Mental Health Commission, the Meadows Mental Health Policy Institute from Texas, Intermountain Health from Utah, One Mind, PsyMed Ventures, GreyMatter Health, leading foundations, and some the largest family office wealth managers in the country, are coming together not only for the summit itself, but to help concrete, measurable systems level initiatives over the next two to three years. If you are active in brain health innovation in digital health, AI, deeptech, virtual reality, digital delivery of care, or health policy innovation, don’t miss it!
BIO Asia–Taiwan 2023
26 Jul 23 - 30 Jul 23
Taiwan + Online Event Platform
Taipei Taiwan
BIO Asia–Taiwan is Asia's largest biotech networking event, and is jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO). The BIO Asia–Taiwan International Conference and Exhibition was held for the first time in 2019. An endorsement of Taiwan's standing as a leading Asian biomedical industry hub, the gathering was a resounding success.
Taipei Taiwan
BIO Asia–Taiwan is Asia's largest biotech networking event, and is jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO). The BIO Asia–Taiwan International Conference and Exhibition was held for the first time in 2019. An endorsement of Taiwan's standing as a leading Asian biomedical industry hub, the gathering was a resounding success.
Contact
Ms. Mia Tsai
Email: mia@taiwanbio.org.tw
Email: mia@taiwanbio.org.tw
Meet us
Representatives from Venture Valuation and Biotechgate will participate in BIO Asia–Taiwan 2023
Biotechgate Digital Partnering August 2023
28 Aug 23 - 01 Sep 23
Online
Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.
Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.
Contact
Mr. Conor Duffy
Email: partnering@biotechgate.com
Email: partnering@biotechgate.com
Meet us
Representatives from Venture Valuation and Biotechgate will participate in Biotechgate Digital Partnering August 2023
BioPharm America™ 2023
13 Sep 23 - 14 Sep 23
Raleigh, North Carolina USA
BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.
Pharma-Biotech Product & Company Valuation Workshop
19 Sep 23 - 19 Sep 23
JW Marriot
Shanghai China
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on Pharma-Biotech Product and Company Valuation. The course will help you: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world Know how to assess and calculate the value of a biotech company Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
Shanghai China
LINGMED LIMITED SHANGHAI together with Venture Valuation is pleased to invite you to a full-day workshop on Pharma-Biotech Product and Company Valuation. The course will help you: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world Know how to assess and calculate the value of a biotech company Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal
Meet us
Representatives from Venture Valuation and Biotechgate will participate in Pharma-Biotech Product & Company Valuation Workshop
ChinaBio® Partnering Forum
20 Sep 23 - 21 Sep 23
Shanghai China
ChinaBio Partnering Forum is the premier life science partnering event in China. The event will attract biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in ChinaBio® Partnering Forum
23rd Annual Biotech in Europe Forum
20 Sep 23 - 21 Sep 23
Mövenpick Hotel
Basel Switzerland
Back for its 23rd Annual Edition, this global bio-pharma industry event will address the main challenges in investment for 2023 as well as partnering and alliance management and prospects for 2024. Key players will contribute their insights in panels, which will cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. The main programme for the 23rd Annual BEF is spread throughout 2 days (20th - 21st of September) and will feature more than 15 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 650+ delegates will register for the forum from all sectors of Life Sciences, with the target audience being corporate and financial investors/partners, banks and advisors, with part of the audience participating virtually.
Basel Switzerland
Back for its 23rd Annual Edition, this global bio-pharma industry event will address the main challenges in investment for 2023 as well as partnering and alliance management and prospects for 2024. Key players will contribute their insights in panels, which will cover the macro picture as well as innovation in different therapeutic sectors. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industry, this event will once again be covered by our regular media partners. The main programme for the 23rd Annual BEF is spread throughout 2 days (20th - 21st of September) and will feature more than 15 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 650+ delegates will register for the forum from all sectors of Life Sciences, with the target audience being corporate and financial investors/partners, banks and advisors, with part of the audience participating virtually.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in 23rd Annual Biotech in Europe Forum
Pharma-Biotech Product & Company Valuation with Dr. P Frei
26 Sep 23 - 26 Sep 23
Brussels
Diegem Belgium
An Introductory Course Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
Diegem Belgium
An Introductory Course Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
Contact
Mr. Annelies Swaan
Email: annelies.swaan@celforpharma.com
Email: annelies.swaan@celforpharma.com
Meet us
Representatives from Venture Valuation and Biotechgate will participate in Pharma-Biotech Product & Company Valuation with Dr. P Frei
BioSpain 2023
26 Sep 23 - 28 Sep 23
Barcelona Spain
BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of our delegates came from outside of Spain. This year, BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one of the most dynamic cities in the world. The event will take place in Pavilion 1 – Fira de Barcelona – Montjuïc. It stands in a superb location in the city center, easily accessible from the airport and well-connected to the public transport network. It is located in Montjuïc Park, an area of cultural and historical interest thanks to its museums and theatres and it also features some of the main tourist attractions in Barcelona.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in BioSpain 2023
BioFuture
04 Oct 23 - 06 Oct 23
New York City USA
BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in BioFuture
AusBiotech 2023
01 Nov 23 - 03 Nov 23
Brisbane Australia
AusBiotech is Australia’s annual flagship industry conference and will continue to advance the biotech community with local and international industry leaders building relationships and having the opportunity to recharge, re-energise and refresh. Last year’s programme saw more than 1,000 delegates and over 150 speakers and chairs, as we reflected on what our sector achieved and networked face-to-face. AusBiotech 2023 will be held at the Brisbane Convention & Exhibition Centre from Wednesday 1 November to Friday 3 November 2023.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in AusBiotech 2023
BIO-Europe® 2023
06 Nov 23 - 08 Nov 23
Munich Germany
BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
Meet us
Representatives from Venture Valuation and Biotechgate will participate in BIO-Europe® 2023
Pharma-Biotech Product & Company Valuation with Dr. P Frei
05 Dec 23 - 05 Dec 23
Diegem Belgium
An Introductory Course: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.
Contact
Mr. Annelies Swaan
Email: annelies.swaan@celforpharma.com
Email: annelies.swaan@celforpharma.com
Meet us
Representatives from Venture Valuation and Biotechgate will participate in Pharma-Biotech Product & Company Valuation with Dr. P Frei
Partners
Upcoming Life Sciences Events
- June 2023
- Boston: Product & Company Valuation Course
- BIO International Convention 2023
- RESI Boston
